ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.63
-0.02 (-0.35%)
Jun 8, 2026, 4:00 PM EDT - Market closed
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $63.5 million as of June 9, 2026.
Market Cap
63.50M
Enterprise Value
-51.29M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.63
Market Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $183.04M to $63.50M, a decrease of -65.31%. That is a compound annual growth rate of -70.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 63.50M | -17.69% |
| Dec 31, 2025 | 77.15M | -57.85% |
| Jul 28, 2025 | 183.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 65.78M |
| MediciNova | 64.48M |
| Seres Therapeutics | 64.20M |
| TScan Therapeutics | 64.17M |
| Filana Therapeutics | 63.77M |
| Acrivon Therapeutics | 61.21M |
| Impact BioMedical | 61.12M |
| PMV Pharmaceuticals | 59.73M |